Stepan (SCL) CEO Rojo receives major equity grants as SAR price corrected
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
STEPAN CO President & CEO Luis Rojo reported several equity compensation awards. On March 2, 2026, he received 57,241 stock appreciation rights with a conversion price of $50.06, 39,952 performance shares, and 19,976 restricted stock units, each tied to one share of common stock. On February 27, 2026, he was granted 56.765 shares of common stock at $52.51. The filing also corrects an earlier Form 4 by revising the SAR conversion price to $50.06 from $17.47 due to an administrative error.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Rojo Luis
Role
President & CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 19,976 | $0.00 | -- |
| Grant/Award | Performance Shares | 39,952 | $0.00 | -- |
| Grant/Award | Stock Appreciation Right | 57,241 | $0.00 | -- |
| Grant/Award | Common Stock | 56.765 | $52.51 | $3K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 19,976 shares (Direct, null);
Performance Shares — 39,952 shares (Direct, null);
Stock Appreciation Right — 57,241 shares (Direct, null);
Common Stock — 15,697.666 shares (Direct, null);
Common Stock — 511.83 shares (Indirect, By Esop II Trust)
Footnotes (1)
- Each RSU represents a contingent right to receive one share of Stepan Company common stock. Vests ratably over three years beginning on the date shown. Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028. This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026 (the "Original Filing"). The Original Filing inadvertently reported an incorrect stock appreciation right ("SAR") conversion/exercise price due to an administrative error in the pricing calculation. The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported. This amendment corrects the reported conversion/exercise price. No other aspects of the reported transaction are affected.
Key Figures
Stock appreciation rights granted: 57,241 rights at $50.06
Performance shares granted: 39,952 shares
Restricted stock units granted: 19,976 RSUs
+5 more
8 metrics
Stock appreciation rights granted
57,241 rights at $50.06
Conversion/exercise price for SARs granted on March 2, 2026
Performance shares granted
39,952 shares
Contingent right to common stock, vesting on performance through December 31, 2028
Restricted stock units granted
19,976 RSUs
Each RSU equals one common share; vests ratably over three years
Common stock grant
56.765 shares at $52.51
Directly held common stock following grant on February 27, 2026
SAR holding after grant
57,241 rights
Total stock appreciation rights following March 2, 2026 transaction
Performance share holding after grant
39,952 shares
Total performance shares following March 2, 2026 transaction
RSU holding after grant
19,976 units
Total restricted stock units following March 2, 2026 transaction
Indirect ESOP II Trust holding
511.83 shares
Common stock held indirectly by Esop II Trust as of February 27, 2026
Key Terms
Stock Appreciation Right, Performance Shares, Restricted Stock Units, Esop II Trust, +2 more
6 terms
Stock Appreciation Right financial
"security_title: Stock Appreciation Right with a conversion price of $50.06"
A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.
Restricted Stock Units financial
"Each RSU represents a contingent right to receive one share of Stepan Company common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Esop II Trust financial
"Common Stock held indirectly with nature of ownership: By Esop II Trust"
Form 4/A regulatory
"This Form 4/A amends the reporting person's original Form 4 filed on March 4, 2026"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
conversion/exercise price financial
"The correct conversion/exercise price for the reported transaction is $50.06 not $17.47 as previously reported."
FAQ
What equity awards did Stepan (SCL) CEO Luis Rojo receive in this Form 4/A?
Luis Rojo received several equity awards: 57,241 stock appreciation rights at a $50.06 conversion price, 39,952 performance shares, 19,976 restricted stock units, and 56.765 shares of common stock granted at $52.51 per share as compensation-related grants.
Why did Stepan (SCL) file an amended Form 4/A for Luis Rojo?
The amended Form 4/A corrects an administrative error in the previously reported stock appreciation right conversion price, changing it from $17.47 to $50.06. No other aspects of the reported transactions, including share amounts or award types, were affected by this correction.
How do the restricted stock units granted to Stepan (SCL) CEO Luis Rojo vest?
Each RSU equals a right to receive one Stepan common share. These restricted stock units vest in equal installments over three years, beginning on the grant date shown, providing a time-based incentive that encourages ongoing service and retention over the vesting period.
Does the Stepan (SCL) Form 4/A show any stock sales by CEO Luis Rojo?
The Form 4/A reflects only compensation-related acquisitions, not open-market stock sales. All coded transactions are grants or awards of stock appreciation rights, performance shares, restricted stock units, and common stock, with no reported buy or sell transactions in the open market.
What indirect Stepan (SCL) holdings are reported for CEO Luis Rojo?
The filing shows an indirect holding of 511.83 Stepan common shares held by an Esop II Trust. This is separate from his directly held equity awards and shares, and is reported as indirect ownership, reflecting shares associated with the trust structure.